129 related articles for article (PubMed ID: 30694726)
1. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics.
Singh M; Guzman-Aranguez A; Hussain A; Srinivas CS; Kaur IP
Nanomedicine (Lond); 2019 Feb; 14(4):465-491. PubMed ID: 30694726
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).
Yadav M; Schiavone N; Guzman-Aranguez A; Giansanti F; Papucci L; Perez de Lara MJ; Singh M; Kaur IP
Drug Deliv Transl Res; 2020 Aug; 10(4):919-944. PubMed ID: 32270439
[TBL] [Abstract][Full Text] [Related]
3. Encapsulating Rifampicin into SLNs: A Viable Option for Managing its Bioavailability Issues Upon Co-Delivery with Isoniazid.
Singh H; Sood R; Chaira T; Khanna A; Upadhaya DJ; Bambal R; Bhatnagar PK; Singh M; Kaur IP
Curr Drug Deliv; 2020; 17(4):343-347. PubMed ID: 32077827
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
Singh H; Bhandari R; Kaur IP
Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991
[TBL] [Abstract][Full Text] [Related]
6. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
7. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
8. Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir).
Kumar R; Sinha VR
AAPS PharmSciTech; 2017 Apr; 18(3):884-894. PubMed ID: 27368921
[TBL] [Abstract][Full Text] [Related]
9. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
11. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
Singh H; Jindal S; Singh M; Sharma G; Kaur IP
Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Xu T; Zhang J; Chi H; Cao F
Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
[TBL] [Abstract][Full Text] [Related]
14. Toxicity studies of highly bioavailable isoniazid loaded solid lipid nanoparticles as per Organisation for Economic Co-operation and Development (OECD) guidelines.
Bhandari R; Singh M; Jindal S; Kaur IP
Eur J Pharm Biopharm; 2021 Mar; 160():82-91. PubMed ID: 33503492
[TBL] [Abstract][Full Text] [Related]
15. Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits.
Liang Z; Zhang Z; Yang J; Lu P; Zhou T; Li J; Zhang J
Int J Nanomedicine; 2021; 16():7847-7857. PubMed ID: 34876813
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.
Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J
Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890
[TBL] [Abstract][Full Text] [Related]
17. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
19. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
Kumar S; Randhawa JK
Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
